PwC: New Global Pharmaceutical and Life Sciences Industry Leader

By Rob Starr, Content Manager, Big4.com

PwC announced recently that Michael Swanick was appointed as Global Pharmaceutical and Life Sciences Industry leader succeeding Simon Friend.

In his expanded role, Swanick also oversees the firm’s capabilities around pharmaceutical and life sciences business strategy, mergers and acquisitions (M&A), research & development (R&D), manufacturing, supply chain, sales & marketing, corporate & financial strategy, risk management, compliance, information technology (IT) systems, intellectual property (IP) management and talent management.

A 28-year veteran of PwC, Swanick most recently held the position of PwC’s U.S. Pharmaceutical and Life Sciences Leader and Global Tax Leader for the practice.  He will continue to serve in this capacity, while taking on additional global responsibilities for the firm.

In his expanded role, Swanick also oversees the firm’s capabilities around pharmaceutical and life sciences business strategy, mergers and acquisitions (M&A), research & development (R&D), manufacturing, supply chain, sales & marketing, corporate & financial strategy, risk management, compliance, information technology (IT) systems, intellectual property (IP) management and talent management.

Earlier in his PwC career, Swanick was the partner-in-charge of international tax services, and served as the lead tax partner on numerous multinational tax clients.  He spent three years in London where he led PwC’s U.S. corporate tax consulting group, and spent two years in Brussels advising publicly traded U.S. and European pharmaceutical companies on their business strategies.  Swanick earned a bachelor’s degree in accounting from St. Joseph’s University in Philadelphia and a master’s degree in taxation from the Villanova University School of Law in Villanova, Pennsylvania.